In PDAC, Gal-3 directly binds and stabilizes active GTP-bound Ras proteins, sustaining downstream MAPK/ERK and PI3K/AKT signaling, which is particularly relevant given the high prevalence of KRAS mutations in pancreatic cancer. The gene discussed is KRAS; the disease is pancreatic neoplasm.